profit off of fear
Find a Conversation
|Sun, 01-10-2010 - 6:16am|
With Big Pharma raking in billions off swine flu fears, the last thing they need is a government handout.
Yet Uncle Sam is busy playing Daddy Warbucks with YOUR lunch money, helping Swiss drugmaker Novartis open a new vaccine plant in North Carolina. You’ve generously contributed around $700 million to help Novartis build their shiny new drug factory — $220 million three years ago, and $486 million this year.
And I’ll bet you didn’t even get a thank-you card.
In return for this bad investment in a foreign company, the U.S. government gets the right to PURCHASE the vaccine for 17 years. Not only that, but these vaccines will be created using a new and unproven biotech method that relies on dog kidneys instead of chicken eggs.
In other words, this plan really is a dog.
I’m a doctor, not an economist. But if this is someone’s idea of stimulus, you do the math: The plant now employs 191 people making an average of $50,000 per year. At that rate, it would take around 75 years for the government money put into this joint to make its way back into our own economy.
Slice off a few years if you believe them when they say they’ll ultimately employ 350 people when the plant is fully operational in 2013 — in any case, it’ll be decades before Americans ever see that cash again.
But don’t worry — I’m sure somewhere, a poor Swiss ski resort is hosting a group of free-spending Novartis executives.
Maybe they’ll be joined by their yodeling friends at the World Health Organization. A report at World Net Daily says at least three of the WHO’s top flu “experts” have financial ties to vaccine makers.
That sure explains a lot.
Meanwhile, anyone who doubts that money is the real driving force behind swine flu fears only needs to check out Business Week magazine.
A recent headline there tells whole story by itself: “How Big Pharma Profits from Swine Flu.”
Careful there, Business Week. That kind of thinking would have gotten you branded a radical conspiracy theorist just a few months ago!
Just check out these big paydays off swine flu vaccine sales:
- $1.7 billion for GlaxoSmithKline
- $700 million for Novartis
- $500 million for Sanofi-Aventis
Those figures are for the fourth quarter of 2009 alone — analysts expect them to grab similar piles of cash for the first quarter of 2010 as everyone from President Obama to Santa Claus push these needless vaccines on you and your children.
Business Week also notes that vaccine sales are booming just in time: Patents on prescription drugs worth a combined $135 billion in annual sales are about to expire… with no new meds ready to replace them.
And that means you can expect another phony swine flu scare any moment now.